SUBJECT INDEX 



985 



nucleic acid biosynthesis, iodoacetate, 



253 



phosphate uptake, iodoacetate, 98 



respiratory quotient, iodoacetate, 135 



transports of substances, 

 arsenite, 703 



2,4-dinitrophenol, 190-191 

 iodoacetate, 175-179, 182, 189-191, 

 248-249 



oxophenarsine, 703 

 phlorizin, 191 

 Intraocular pressure, iodoacetate, 239 

 Invertase, see ^-Fructofuranosidase 

 Iodide, 



active transports of. iodoacetate, 177, 



186 



uptake by ciliary body, iodoacetate, 



240 



uptake by thyroid, 

 arsenite, 703 

 quinones, 494 

 Iodine, 



fructose- 1 ,6-diphosphatase, 804 



thiosulfate transsulfurase, 814 

 lodoacetamide, see also Iodoacetate for 



all general topics, 



carbamylmethylation of proteins, 16- 



17 



comparison with iodoacetate, 271-274 



mitochondrial swelling, 98 



permeability to, 271 



preparation of, 8 

 Iodoacetate, 



acetate oxidation, 93, 95-96 



active transport, 171-181, 185-195 



actomyosin, 208 



alcohol dehydrogenase, 25-27 



amino acid metabolism, 146-153 



ATPase, 35-36 



ATP levels in tissues, 99-100, 102-105, 



204-205, 242 



auxin actions and transport, 256-257 



bacterial growth, 266-267 



bioluminescence, 276 



carcinostasis, 260-261, 263-266 



C-l/C-6 ratio, 129-131 



central nervous system, 246-247 



chemical properties, 7-18 



cholesterol biosynthesis, 262 



chromosomal effects, 254-255 



C-I bond characteristics, 7-8 



ciliary motility, 243 



citrate levels in tissues, 97-98 



cobalt uptake in vivo, 194-196 



coeliac disease, relation to inestinal 



effects, 251 



coenzyme A levels in tissues, 96 



CO2 fixation, 166-167 



comparison with iodoacetamide, 271- 



274 



comparison with other haloacetates, 



274-277 



contracture, 3-4, 197, 199-209, 221-223, 



225, 227-228 



Crabtree effect. 111, 138-139, 262 



creatine kinase, 36-39, 205-206 



creatine-P levels in tissues, 99-100, 103 



dermatitis, 243-244, 250 



electron transport, 52, 58-60 



Entner-Doudorotf pathway, 125, 128 



enzyme inhibitions, 18-52 



comparison with other SH reagents, 



818 



group introduced onto protein, 17 



interpretation of partial inhibitions, 



51 



pH effects, 33-34, 38, 45-46 



rates of inhibitions, 49-50 



reversibility, 48-49 

 estrus cycle, 250 

 fatty acid biosynthesis, 145, 262 

 fatty acid oxidation, 140, 144 

 fertilization, 243, 259 

 fungal growth, 269 

 ganglionic transmission, 231 

 gastric acid secretion, 176, 184 

 gastric motility, 226 

 glucose oxidation. 111, 122-139 

 glucosuria, 192 

 glycerol oxidation, 144 

 glycolysis, localization of site of action, 

 4-7, 69-70, 74-82 



glycolysis (aerobic), 101, 106-109, 241, 

 261 



glycolysis (anaerobic), 5, 61-86 

 growth, 254-265 



